Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
60,893,283
-
Total 13F shares
-
8,659,890
-
Share change
-
-44,872
-
Total reported value
-
$3,389,920
-
Put/Call ratio
-
0.75%
-
Price per share
-
$0.39
-
Number of holders
-
23
-
Value change
-
-$48,128
-
Number of buys
-
8
-
Number of sells
-
9
Institutional Holders of Equillium, Inc. - Common Stock (EQ) as of Q1 2025
As of 31 Mar 2025,
Equillium, Inc. - Common Stock (EQ) was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,659,890 shares.
The largest 10 holders included
Decheng Capital LLC, TAKEDA PHARMACEUTICAL CO LTD, VANGUARD GROUP INC, Cota Capital Management, LLC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, ACADIAN ASSET MANAGEMENT LLC, Callan Capital, LLC, STATE STREET CORP, and CITADEL ADVISORS LLC.
This page lists
23
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.